Bio-Rad Laboratories(BIO-N)NYSE
Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Pre Market Change
Pre Market Last Update Pre Market Price
Volume
Latest News
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
Business Wire - Mon May 8, 7:00AM CDT
Business Wire
Mon May 8, 7:00AM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during the 2023 RBC Capital Markets...
A Surge in Regional Banks and Strong Apple Earnings Boost Stocks
Barchart - Fri May 5, 3:31PM CDT
Barchart
Fri May 5, 3:31PM CDT
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.13%. Stock indexes Friday rallied sharply, with the Nasdaq 100...
Stocks Jump as Bank Stock Rebound and Apple Soars
Barchart - Fri May 5, 10:14AM CDT
Barchart
Fri May 5, 10:14AM CDT
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +1.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.45%. U.S. stocks this morning are moderately higher as an...
Bio-Rad Reports First-Quarter 2023 Financial Results
Business Wire - Thu May 4, 3:15PM CDT
Business Wire
Thu May 4, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2023.
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
Business Wire - Wed Apr 12, 3:11PM CDT
Business Wire
Wed Apr 12, 3:11PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the first quarter of 2023 on Thursday, May 4, 2023, following the close of the...
Resolve Biosciences Announces Appointment of John Stark as Chief Executive Officer
Business Wire - Wed Mar 15, 6:58AM CDT
Business Wire
Wed Mar 15, 6:58AM CDT
Resolve Biosciences, a company pioneering Molecular Cartography™ technology, announced today that it has appointed John Stark as Chief Executive Officer. As part of this transition, Resolve Biosciences’ previous CEO, Jason Gammack, will be leaving...
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
Business Wire - Fri Feb 17, 8:00AM CST
Business Wire
Fri Feb 17, 8:00AM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Citi’s 2023 Healthcare...
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
Business Wire - Thu Feb 16, 3:05PM CST
Business Wire
Thu Feb 16, 3:05PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2022.
Stocks Rally on Expectations for a Dovish U.S. CPI Report
Barchart - Wed Jan 11, 3:46PM CST
Barchart
Wed Jan 11, 3:46PM CST
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +1.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.80%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.76%. Stocks on Wednesday extended Tuesday’s gains, with the S&P...
Stocks Climb on Hopes for U.S. Consumer Prices to Soften
Barchart - Wed Jan 11, 10:19AM CST
Barchart
Wed Jan 11, 10:19AM CST
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. Stock indexes this morning are moderately higher, with the...